S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
VCEL · Vericel Corporation
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$40.96
+0.39
(+0.96%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$40.96
$40.22
$40.98
52-WEEK RANGE
$40.96
$28.95
$49.32
What's happening
- VCEL is up 0.96% today, trading at $40.96. — Live quote
- Volume today (28,385) is well below its 3-month average of 554,970. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.04 actual vs. $-0.03 estimated (+239.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 7
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (14 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
VCEL
+12.69%
vs S&P 500
-0.09%
1-YEAR RETURN
VCEL
+12.66%
vs S&P 500
-1.90%
6-MONTH RETURN
VCEL
+20.17%
3-MONTH RETURN
VCEL
-12.05%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.04
Est. $-0.03
BEAT +239.4%
2026-04-26 (Q1 2026)
$-0.12
Est. $-0.16
BEAT +24.1%
2026-01-26 (Q4 2025)
$0.45
Est. $0.40
BEAT +13.1%
2025-10-26 (Q3 2025)
$0.10
Est. $-0.01
BEAT +1662.5%
Valuation Measures & Ratios
Enterprise Value4$1.92B
Forward P/E551.17
PEG Ratio60.33
Price / Sales (TTM1)6.68
Price / Book76.14
EV4 / Revenue6.27
EV4 / EBITDA61.69
Profit Margin7.91%
Operating Margin5.95%
Return on Equity (ROE8)6.91%
Return on Assets (ROA9)5.02%
Avg Volume (3M)554,970
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $2.45B | $1.69B | $1.60B | $2.36B | $2.18B |
| P/E | 5768.69 | -129.73 | -209.45 | -135.80 | -105.30 |
| Price/Sales | 8.86 | 6.71 | 6.62 | 10.43 | 10.16 |
| Price/Book | 6.63 | 4.74 | 4.96 | 7.69 | 7.37 |
| EV/Revenue | 8.41 | 6.28 | 6.20 | 10.07 | 9.82 |
| EV/EBITDA | 360.78 | -204.97 | -369.24 | — | — |
| ROE | 0.11% | -3.66% | -2.37% | -5.67% | -7.00% |
| ROA | 0.08% | -2.68% | -1.68% | -3.99% | -4.87% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short5,202,417
Change from Prior Settlement-5.12%
% of Float—
Days to Cover (Short Ratio)9.64
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 22.5% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +12.7%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is 7.9%. Finnhub fundamentals ↗
- Trailing P/E is 84.5, a high price relative to reported earnings. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-08-14; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on VCEL
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $77.5M | $68.4M | $67.5M | $63.2M | $52.6M | $57.9M | $52.7M | $51.3M |
| Gross profit | $56.4M | $49.3M | $49.6M | $46.6M | $36.3M | $41.7M | $36.6M | $35.4M |
| Operating income | $434.0K | -$8.1M | $3.5M | -$2.0M | -$12.8M | -$2.5M | -$6.0M | -$5.5M |
| Net income | $2.2M | -$6.3M | $5.1M | -$553.0K | -$11.2M | -$901.0K | -$4.7M | -$3.9M |
| EPS (diluted) | $0.04 | $-0.12 | $0.10 | $-0.01 | $-0.23 | $-0.02 | $-0.10 | $-0.08 |
| EPS (basic) | $0.04 | $-0.12 | $0.10 | $-0.01 | $-0.23 | $-0.02 | $-0.10 | $-0.08 |
| Operating margin | $1 | -$12 | $5 | -$3 | -$24 | -$4 | -$11 | -$11 |
| Net margin | $3 | -$9 | $8 | -$1 | -$21 | -$2 | -$9 | -$8 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $502.9M | $485.6M | $488.0M | $453.3M | $435.6M | $424.6M | $432.7M | $390.4M |
| Total liabilities | $132.8M | $129.4M | $133.3M | $131.4M | $128.8M | $129.1M | $140.8M | $132.9M |
| Stockholders' equity | $370.0M | $356.2M | $354.6M | $321.9M | $306.8M | $295.5M | $292.0M | $257.5M |
| Total current assets | $264.7M | $244.1M | $247.4M | $222.0M | $204.6M | $197.6M | $212.8M | $190.5M |
| Total current liabilities | $52.5M | $47.2M | $49.1M | $45.6M | $41.1M | $39.4M | $50.3M | $41.3M |
| Cash & equivalents | $125.4M | $109.3M | $100.1M | $100.4M | $80.5M | $73.5M | $74.5M | $53.7M |
| Marketable securities (current) | $37.1M | $36.0M | $37.4M | $35.0M | $36.3M | $39.4M | $41.7M | $48.1M |
| Accounts receivable | $75.7M | $72.4M | $84.6M | $60.4M | $64.3M | $52.9M | $61.4M | $48.5M |
| Inventory | $18.4M | $18.4M | $17.6M | $18.2M | $16.8M | $17.1M | $17.4M | $15.8M |
| Other current assets | $8.2M | $8.0M | $7.7M | $8.0M | $6.6M | $8.5M | $7.3M | $7.9M |
| Property, plant & equipment | — | — | — | — | — | — | — | — |
| Intangible assets | $5.3M | $5.5M | $5.6M | $5.8M | $5.9M | $6.1M | $6.2M | $6.4M |
| Other non-current assets | $233.0K | $288.0K | $341.0K | $395.0K | $447.0K | $501.0K | $556.0K | $610.0K |
| Accounts payable | $20.6M | $19.0M | $15.8M | $15.3M | $12.9M | $16.8M | $23.8M | $20.9M |
| Accrued liabilities | $17.6M | $14.0M | $19.2M | $16.3M | $14.4M | $11.4M | $17.1M | $14.3M |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | $116.0K | $116.0K | $116.0K | $116.0K | $118.0K | $116.0K | $116.0K | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $1.9M | $1.9M | $1.9M | $1.7M | $1.7M | $1.8M | $876.0K | $243.0K |
| Common stock & paid-in capital | $750.8M | $739.0M | $730.7M | $721.1M | $711.2M | $699.4M | $684.8M | $669.7M |
| Retained earnings | -$380.4M | -$382.6M | -$376.3M | -$399.5M | -$404.6M | -$404.1M | -$392.8M | -$412.6M |
| Accumulated other comprehensive income (loss) | -$365.0K | -$168.0K | $275.0K | $258.0K | $183.0K | $136.0K | $4.0K | $359.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $16.2M | $16.4M | $15.0M | $22.1M | $8.2M | $6.6M | $22.2M | $10.2M |
| Investing cash flow | -$2.8M | -$4.2M | -$16.4M | -$3.4M | -$9.0M | -$15.1M | -$14.7M | -$21.2M |
| Financing cash flow | $2.7M | -$3.0M | $1.1M | $1.2M | $1.6M | $3.2M | $7.1M | $5.5M |
| Free cash flow | $14.3M | $15.1M | $12.8M | $19.5M | $81.0K | -$7.6M | $8.5M | -$9.2M |
| Capital expenditures | $1.9M | $1.3M | $2.2M | $2.6M | $8.1M | $14.2M | $13.8M | $19.4M |
| Depreciation & amortization | $3.6M | $3.3M | $3.1M | $2.9M | $2.8M | $2.7M | $1.5M | $1.3M |
| Share-based compensation | $9.1M | $11.3M | $8.4M | $8.7M | $10.1M | $11.5M | $7.9M | $9.2M |
| Change in inventory | $183.0K | $964.0K | $448.0K | $1.3M | -$275.0K | -$267.0K | $1.6M | $869.0K |
| Change in accounts payable | $1.6M | $2.6M | $713.0K | $2.8M | $8.0K | -$551.0K | $1.4M | -$1.4M |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Other investing activities | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $143.0K | $4.5M | $169.0K | $305.0K | $136.0K | $6.2M | $153.0K | $271.0K |
| Other financing activities | -$23.0K | -$21.0K | -$21.0K | -$11.0K | -$11.0K | -$4.0K | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $276.3M | $237.2M | $197.5M | $164.4M | $156.2M |
| Gross profit | $205.6M | $172.1M | $135.6M | $109.8M | $106.0M |
| Operating income | $11.0M | $4.5M | -$6.5M | -$17.1M | -$7.9M |
| Net income | $16.5M | $10.4M | -$3.2M | -$16.7M | -$7.5M |
| EPS (diluted) | $0.32 | $0.20 | $-0.07 | $-0.35 | $-0.16 |
| EPS (basic) | $0.33 | $0.21 | $-0.07 | $-0.35 | $-0.16 |
| Operating margin | $4 | $2 | -$3 | -$10 | -$5 |
| Net margin | $6 | $4 | -$2 | -$10 | -$5 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $488.0M | $432.7M | $353.7M | $273.0M | $243.7M |
| Total liabilities | $133.3M | $140.8M | $127.7M | $80.7M | $73.2M |
| Stockholders' equity | $354.6M | $292.0M | $226.0M | $192.3M | $170.5M |
| Total current assets | $247.4M | $212.8M | $205.6M | $186.9M | $158.5M |
| Total current liabilities | $49.1M | $50.3M | $45.7M | $37.5M | $26.1M |
| Cash & equivalents | $100.1M | $74.5M | $69.1M | $51.1M | $68.3M |
| Marketable securities (current) | $37.4M | $41.7M | $40.5M | $68.5M | $35.1M |
| Accounts receivable | $84.6M | $61.4M | $58.4M | $46.5M | $37.4M |
| Inventory | $17.6M | $17.4M | $13.1M | $16.0M | $13.4M |
| Other current assets | $7.7M | $7.3M | $6.9M | $4.8M | $4.2M |
| Property, plant & equipment | — | — | — | — | — |
| Intangible assets | $5.6M | $6.2M | $6.9M | $7.5M | $0 |
| Other non-current assets | $341.0K | $556.0K | $771.0K | $1.3M | $317.0K |
| Accounts payable | $15.8M | $23.8M | $22.3M | $16.9M | $9.0M |
| Accrued liabilities | $19.2M | $17.1M | $17.2M | $16.2M | $14.0M |
| Short-term debt | — | — | — | — | — |
| Other current liabilities | $116.0K | $116.0K | $0 | $41.0K | $41.0K |
| Long-term debt | — | — | — | — | — |
| Other non-current liabilities | $1.9M | $876.0K | $100.0K | $0 | $44.0K |
| Common stock & paid-in capital | $730.7M | $684.8M | $629.2M | $593.2M | $553.9M |
| Retained earnings | -$376.3M | -$392.8M | -$403.2M | -$400.0M | -$383.3M |
| Accumulated other comprehensive income (loss) | $275.0K | $4.0K | -$100.0K | -$978.0K | -$154.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $51.9M | $58.2M | $35.3M | $17.7M | $29.0M |
| Investing cash flow | -$43.9M | -$79.0M | -$3.1M | -$36.2M | -$3.5M |
| Financing cash flow | $7.1M | $19.1M | $3.6M | $1.0M | $9.2M |
| Free cash flow | $24.7M | -$5.8M | $15.3M | $10.1M | $21.1M |
| Capital expenditures | $27.2M | $64.0M | $20.0M | $7.6M | $7.9M |
| Depreciation & amortization | $11.5M | $5.5M | $4.6M | $4.0M | $3.0M |
| Share-based compensation | $38.8M | $36.5M | $32.3M | $37.2M | $34.3M |
| Change in inventory | $1.2M | $4.3M | -$2.9M | $2.6M | $4.0M |
| Change in accounts payable | $3.0M | -$287.0K | $3.0M | $1.4M | $1.5M |
| Other investing activities | — | — | — | — | — |
| Debt repaid | — | — | — | — | — |
| Tax withholding on stock comp | $6.8M | $5.5M | $2.3M | $1.5M | $1.7M |
| Other financing activities | -$47.0K | $0 | -$41.0K | -$39.0K | -$348.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding VCEL as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-02 to 2026-08-12
Recent transactions
- Insiders have net sold 110,462 shares over the last 182 days, across 0 purchases and 21 sales.
- Most recent: MCLAUGHLIN KEVIN F (Reporting person) — Option exercise of 7,000 shares on 2026-08-12.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)110,462 sh(21 txns)
Net Shares-110,462
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| MCLAUGHLIN KEVIN F | Reporting person | Option exercise | 2026-08-12 | 7,000 |
| Halpin Michael | Chief Operating Officer | Option exercise | 2026-08-03 | 10,000 |
| SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 2026-07-30 | 1,500 |
| Mara Joseph Anthony Jr | Chief Financial Officer | Open market sale | 2026-06-26 | 5,000 |
| Hopper Jonathan Mark | Chief Medical Officer | Option exercise | 2026-06-26 | 5,000 |
| Flynn Sean C. | Chief Legal Officer | Option exercise | 2026-06-26 | 15,000 |
| Wotton Paul K | Reporting person | Open market sale | 2026-05-11 | 2,500 |
| Hagen Heidi | Reporting person | Option exercise | 2026-04-29 | 3,200 |
| Rubino Alan L | Reporting person | Option exercise | 2026-04-29 | 3,200 |
| WRIGHT LISA | Reporting person | Option exercise | 2026-04-29 | 3,200 |
| ZERBE ROBERT L MD | Reporting person | Option exercise | 2026-04-29 | 3,200 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-12 | MCLAUGHLIN KEVIN F | Reporting person | Option exercise | 7,000 | $13.05 |
| 2026-08-12 | MCLAUGHLIN KEVIN F | Reporting person | Open market sale | 7,000 | $44.53 |
| 2026-08-03 | Halpin Michael | Chief Operating Officer | Option exercise | 10,000 | $16.66 |
| 2026-08-03 | Halpin Michael | Chief Operating Officer | Open market sale | 10,000 | $46.84 |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 1,500 | $34.90 |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Open market sale | 1,500 | $48.90 |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 2,500 | $29.82 |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Open market sale | 2,500 | $48.90 |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 500 | $29.82 |
| 2026-07-30 | SIEGAL JONATHAN | Principal Accounting Officer | Open market sale | 500 | $48.90 |
| 2026-06-26 | SIEGAL JONATHAN | Principal Accounting Officer | Open market sale | 232 | $44.90 |
| 2026-06-26 | SIEGAL JONATHAN | Principal Accounting Officer | Option exercise | 2,500 | $29.82 |
| 2026-06-26 | SIEGAL JONATHAN | Principal Accounting Officer | Open market sale | 2,500 | $44.90 |
| 2026-06-26 | Mara Joseph Anthony Jr | Chief Financial Officer | Open market sale | 5,000 | $44.75 |
| 2026-06-26 | Hopper Jonathan Mark | Chief Medical Officer | Option exercise | 5,000 | $29.82 |
| 2026-06-26 | Hopper Jonathan Mark | Chief Medical Officer | Open market sale | 5,000 | $45.00 |
| 2026-06-26 | Hopper Jonathan Mark | Chief Medical Officer | Option exercise | 5,000 | $29.82 |
| 2026-06-26 | Hopper Jonathan Mark | Chief Medical Officer | Open market sale | 5,000 | $45.00 |
| 2026-06-26 | Flynn Sean C. | Chief Legal Officer | Option exercise | 15,000 | $16.25 |
| 2026-06-26 | Flynn Sean C. | Chief Legal Officer | Open market sale | 15,000 | $45.64 |
| 2026-06-18 | Halpin Michael | Chief Operating Officer | Option exercise | 10,000 | $16.66 |
| 2026-06-18 | Halpin Michael | Chief Operating Officer | Open market sale | 10,000 | $40.24 |
| 2026-06-18 | Flynn Sean C. | Chief Legal Officer | Option exercise | 15,000 | $16.25 |
| 2026-06-18 | Flynn Sean C. | Chief Legal Officer | Open market sale | 15,000 | $40.21 |
| 2026-06-02 | Hopper Jonathan Mark | Chief Medical Officer | Option exercise | 4,375 | $16.66 |
| 2026-06-02 | Hopper Jonathan Mark | Chief Medical Officer | Open market sale | 4,375 | $35.00 |
| 2026-05-13 | MCLAUGHLIN KEVIN F | Reporting person | Option exercise | 3,500 | $2.63 |
| 2026-05-13 | MCLAUGHLIN KEVIN F | Reporting person | Open market sale | 3,500 | $32.83 |
| 2026-05-13 | MCLAUGHLIN KEVIN F | Reporting person | Option exercise | 3,500 | $13.05 |
| 2026-05-13 | MCLAUGHLIN KEVIN F | Reporting person | Open market sale | 3,500 | $32.82 |
| 2026-05-11 | Wotton Paul K | Reporting person | Open market sale | 2,500 | $33.05 |
| 2026-05-11 | Wotton Paul K | Reporting person | Open market sale | 7,500 | $32.64 |
| 2026-05-07 | Mara Joseph Anthony Jr | Chief Financial Officer | Open market sale | 5,000 | $40.50 |
| 2026-05-07 | SIEGAL JONATHAN | Principal Accounting Officer | Open market sale | 1,422 | $40.50 |
| 2026-05-06 | SIEGAL JONATHAN | Principal Accounting Officer | Open market sale | 3,433 | $38.00 |
| 2026-04-29 | MCLAUGHLIN KEVIN F | Reporting person | Option exercise | 3,200 | — |
| 2026-04-29 | Hagen Heidi | Reporting person | Option exercise | 3,200 | — |
| 2026-04-29 | Rubino Alan L | Reporting person | Option exercise | 3,200 | — |
| 2026-04-29 | Wotton Paul K | Reporting person | Option exercise | 3,200 | — |
| 2026-04-29 | WRIGHT LISA | Reporting person | Option exercise | 3,200 | — |
| 2026-04-29 | ZERBE ROBERT L MD | Reporting person | Option exercise | 3,200 | — |
| 2026-04-02 | Hopper Jonathan Mark | Chief Medical Officer | Option exercise | 3,472 | $10.95 |
| 2026-04-02 | Hopper Jonathan Mark | Chief Medical Officer | Open market sale | 3,472 | $35.00 |
| 2026-03-25 | Rubino Alan L | Reporting person | Option exercise | 15,000 | $2.76 |
| 2026-03-23 | Hagen Heidi | Reporting person | Option exercise | 15,000 | $2.76 |
| 2026-03-23 | Hagen Heidi | Reporting person | Open market sale | 15,000 | $32.41 |
| 2026-03-02 | Flynn Sean C. | Chief Legal Officer | Open market sale | 6,421 | $34.75 |
| 2026-03-02 | Flynn Sean C. | Chief Legal Officer | Option exercise | 15,000 | $16.25 |
| 2026-03-02 | Flynn Sean C. | Chief Legal Officer | Open market sale | 15,000 | $35.36 |
| 2026-03-02 | Halpin Michael | Chief Operating Officer | Open market sale | 10,305 | $35.30 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 02:07 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-14 | 4 | 2026-08-12 | View on SEC.gov → |
| 2026-08-05 | 4 | 2026-08-03 | View on SEC.gov → |
| 2026-07-31 | 4 | 2026-07-30 | View on SEC.gov → |
| 2026-07-30 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-30 | 8-K | 2026-07-30 | View on SEC.gov → |
| 2026-06-30 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-30 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-30 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-30 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-02 | View on SEC.gov → |
Recent news
Headlines about VCEL (Vericel Corporation). Links open the publisher — we don’t host full articles.
-
VCEL270416P00060000 Interactive Stock Chart | VCEL Apr 2027 60.000 put Stock
Yahoo Finance · 2026-10-21 -
VCEL Apr 2027 30.000 put (VCEL270416P00030000) Interactive Stock Chart - Yahoo Finance
Yahoo! Finance Canada · 2026-10-20 -
VCEL Apr 2027 25.000 put (VCEL270416P00025000) stock price, news, quote and history
Yahoo Finance UK · 2026-10-19 -
VCEL270416P00040000 interactive stock chart | VCEL Apr 2027 40.000 put stock
Yahoo Finance Australia · 2026-10-18 -
Vericel (VCEL) And The Burn Care Story Behind Its Undervalued View
Simply Wall Street · 2026-10-18 -
Truist Securities Maintains Buy on Vericel, Lowers Price Target to $52
Benzinga · 2026-10-14 -
Vericel (VCEL) Stock Looks Fully Priced After A 31% Gain
Yahoo Finance · 2026-09-26 -
Vericel Corporation (VCEL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha · 2026-09-15
No headlines in this category right now — try “All”.